Blas Betancourt, M.D.

Blas Betancourt, M.D.

(352) 265-4846

Current patients:
Log in to MyUFHealth

Publications

Sarcoidosis Concomitant With Takayasu Arteritis, Identified by Advanced Molecular Imaging.
Arthritis & rheumatology (Hoboken, N.J.)
2019

Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors.
Rheumatic diseases clinics of North America
2018

Pulmonary aspergillosis presenting with recurrent haemoptysis.
BMJ case reports
2015

Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.
International wound journal
2009

Management of a hypertensive ulcer with an epidermal growth factor-based formulation.
Journal of wound care
2008

Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
International wound journal
2007

Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients.
Journal of thrombosis and thrombolysis
2006

Recombinant streptokinase: evidences from clinical use.
European heart journal
2005

Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
BMC clinical pharmacology
2005

Angiographic patency study of an albumin-free recombinant streptokinase formulation in acute myocardial infarction.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
2004

Streptokinase for the treatment of acute ischaemic stroke : towards better strategies.
CNS drugs
2003